NH Rev Stat § 318-B:49 (2021)
2021 New Hampshire Revised Statutes|Title XXX - Occupations and Professions|Title 318-B - Controlled Drug Act|Section 318-B:49 - Electronic Registry System.

    318-B:49 Electronic Registry System. –||I. (a) Retail establishments shall use an electronic registry system to record the sale of products made pursuant to RSA 318-B:48. The electronic registry system shall have the capacity to block a sale of nonprescription drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine that would result in a purchaser exceeding the lawful daily or monthly amount. The system shall contain an override function that may be used by an agent of a retail establishment who is dispensing the drug product and who has a reasonable fear of imminent bodily harm to his or her person or to another person if the transaction is not completed. The system shall create a record of each use of the override mechanism.||(b) The electronic registry system shall be available free of charge to the state of New Hampshire, retail establishments, and local law enforcement agencies.||(c) The electronic registry system shall operate in real time to enable communication among in-state users and users of similar systems in neighboring states.||(d) The state shall use the National Precursor Log Exchange (NPLEx) online portal or its equivalent to host New Hampshire's electronic registry system.||II. (a) Prior to completing a sale under RSA 318-B:48, a retail establishment shall require the person purchasing the drug product to present a current, valid government-issued identification document. The retail establishment shall record in the electronic registry system:||(1) The name and address of the purchaser;||(2) The name of the drug product and quantity of ephedrine, pseudoephedrine, and phenylpropanolamine sold in grams;||(3) The date and time of purchase;||(4) The form of identification presented, the issuing government entity, and the corresponding identification number; and||(5) The name of the person selling or furnishing the drug product.||(b)(1) If the retail establishment experiences an electronic or mechanical failure of the electronic registry system and is unable to comply with the electronic recording requirement, the retail establishment shall maintain a written log or an alternative electronic recordkeeping mechanism until the retail establishment is able to comply fully with this subdivision.||(2) If the region of the state where the retail establishment is located does not have broadband Internet access, the retail establishment shall maintain a written log or an alternative electronic recordkeeping mechanism until broadband Internet access becomes accessible in that region. At that time, the retail establishment shall come into compliance with this subdivision.||(c) A retail establishment shall maintain all records of drug product purchases made pursuant to this subdivision for a minimum of 2 years.||III. A retail establishment shall display a sign at the register provided by NPLEx or its equivalent to notify purchasers of drug products containing ephedrine, pseudoephedrine, or phenylpropanolamine that:||(a) The purchase of the drug product or products shall result in the purchaser's identity being listed on a national database; and||(b) The purchaser has the right to request the transaction number for any purchase that was denied pursuant to this subdivision.|||Source. 2018, 124:1, eff. Jan. 1, 2019.|